期刊文献+

供体MSCs来源的外泌体转运miR-26a恢复宿主MSCs功能并缓解骨质疏松 被引量:9

Rescue of recipient MSC functions and remission of recipient osteoporosis by donor MSC-derived exosomes through transfer of miR-26a
下载PDF
导出
摘要 目的:探讨移植的供体间充质干细胞(mesenchymal stem cells,MSCs)通过分泌外泌体缓解雌激素缺乏导致的骨质疏松的机制。方法:建立12只小鼠雌激素缺乏骨质疏松模型,通过siRNA调控MSCs外泌体释放及直接注射外泌体,明确外泌体的分泌在MSCs治疗骨质疏松中的作用;通过体外成骨分化诱导、茜素红染色、qPCR明确供体MSCs来源的外泌体对宿主MSCs功能的影响;通过miR-26a模拟物、抑制物转染、qPCR明确外泌体发挥治疗作用的机制。结果:供体MSCs通过分泌外泌体缓解雌激素缺乏骨质疏松,并证明外泌体通过恢复骨质疏松宿主MSCs成骨分化功能缓解骨质疏松,外泌体可通过转运miR-26a恢复骨质疏松宿主MSCs的成骨分化功能。结论:供体MSCs来源的外泌体可通过转运miR-26a恢复宿主MSCs功能并缓解骨质疏松。 Objective: To explore mechanisms underlying the rescuing effects of transplanted mesenchymal stem cells (MSCs) derived exosomes on estrogen-deficient osteoporosis. Methods: Mouse estrogen-deficient osteoporosis model was constructed in 12 female C57BL6/J rats and the exosome release was regulated by siRNA. Osteogenic induction, alizarin red staining and qPCR were performed to evaluate the effects of exosomes on recipient MSC functions. The miR-26a mimics and inhibitors and qPCR were used to explore the mechanisms underlying exosome-mediated functional rescue of recipient MSCs. Results: Donor MSCs alleviated estrogen-deficient osteoporosis via exosome release, and the alleviated osteoporosis by exosomes rescued the recipient MSC functions were observed. Moreover, the rescued recipient MSC functions by exosomes transferred miR-26a were found. Conclusion: Donor MSC-derived exosomes may rescue MSC functions and may remit osteoporosis of the recipient through transfering miR-26a.
出处 《实用口腔医学杂志》 CSCD 北大核心 2017年第5期575-579,共5页 Journal of Practical Stomatology
基金 国家自然科学基金面上项目(编号:31670995)
关键词 间充质干细胞(MSCs) 骨质疏松 外泌体 Mesenchymal stem cells (MSCs) Osteoporosis Exosomes
  • 相关文献

参考文献2

二级参考文献32

  • 1Jiang Y,Jahagirdar BN,Reinhardt RL,et al.Pluripotency of mesenchymal stem cells derived from adult marrow [J].Nature,2002,418(6893):41-49.
  • 2Reya T,Morrison S J,Clarke MF,et al.Stem cells,canc-er,and cancer stem cells [J].Nature,2001,414(6859):105-111.
  • 3Bergfeld SA,DeClerck YA.Bone marrow-derived mesen-chymal stem cells and the tumor microenvironment [J].Cancer Metastasis Rev,2010,29(2):249-261.
  • 4Tu Q,Valverde P,Chen J.Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells [J].Biochem Biophys Res Commun,2006,341(4):1257-1265.
  • 5Friedenstein AJ,Piatetzky-Shapiro II,Petrakova KV.Osteo-genesis in transplants of bone marrow cells [J].J EmbryolExp Morphol,1966,16(3):381-390.
  • 6Horwitz EM,Prockop D J,Fitzpatrick LA,et al.Transplant-ability and therapeutic effects of bone marrow-derived mes-enchymal cells in children with osteogenesis imperfecta [J].Nat Med,1999,5(3):309-313.
  • 7Pittenger MF,Mackay AM,Beck SC,et al.Muhilineage po-tential of adult human mesenchymal stem cells [J].Science,1999,284(5411):143-147.
  • 8Zhou S,Greenberger JS,Epperly MW,et al.Age-related in-trinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts [J].Aging Cell,2008,7(3):335-343.
  • 9Pignolo R J,Suda RK,McMillan EA,et al.Defects in te-lomere maintenance molecules impair osteoblast differentia-tion and promote osteoporosis[J].Aging Cell,2008,7(1):23-31.
  • 10Huang Z,Ren PG,Ma T,et al.Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availabil-ity[J].Cytokine,2010,51(3):305-310.

共引文献1

同被引文献52

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部